J Liver Cancer.  2016 Sep;16(2):129-133. 10.17998/jlc.2016.16.2.129.

A Case of Management for Hepatocellular Carcinoma with Lung Metastasis

Affiliations
  • 1Department of Internal Medicine, Korea University Anam Hospitial, Seoul, Korea. lacid@korea.ac.kr
  • 2Department of Surgery, Korea University Anam Hospitial, Seoul, Korea.

Abstract

Liver cancer is the 2nd most common cause of cancer related death in Korea. Especially, patients who present extrahepatic spread of hepatocellular carcinoma (HCC) have a shorter life expectancy (50% survival at 1 year and less than 4 months of median overall survival). Molecular target agent like sorafenib was usually mentioned as a treatment for them, but that was still not firmly established. We present a 75 year-old who had expanding nodular type of HCC. The mass was removed by resection and radiofrequency ablation. However, lung metastasis were revealed shortly after surgery. That lesions were treated with lenvatinib and systemic chemotherapy.

Keyword

Hepatocellular carcinoma; Metastasis; Molecular targeted therapy; Chemotherapy

MeSH Terms

Carcinoma, Hepatocellular*
Catheter Ablation
Drug Therapy
Humans
Korea
Life Expectancy
Liver Neoplasms
Lung*
Molecular Targeted Therapy
Neoplasm Metastasis*
Full Text Links
  • JLC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr